Cargando…
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
BACKGROUND: Besides major clinical/biochemical features, neutropenia and inflammatory bowel disease (IBD) constitute common complications of Glycogen storage disease type Ib (GSD Ib). However, their management is still challenging. Although previous reports have shown benefit of empagliflozin admini...
Autores principales: | Rossi, Alessandro, Miele, Erasmo, Fecarotta, Simona, Veiga-da-Cunha, Maria, Martinelli, Massimo, Mollica, Carmine, D’Armiento, Maria, Mozzillo, Enza, Strisciuglio, Pietro, Derks, Terry G. J., Staiano, Annamaria, Parenti, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254289/ https://www.ncbi.nlm.nih.gov/pubmed/34215305 http://dx.doi.org/10.1186/s13052-021-01100-w |
Ejemplares similares
-
Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023) -
Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report
por: Makrilakis, Konstantinos, et al.
Publicado: (2022) -
Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report
por: Calia, Margherita, et al.
Publicado: (2023) -
Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
por: Grünert, Sarah C., et al.
Publicado: (2020) -
Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
por: Tallis, Eran, et al.
Publicado: (2022)